Disseminated intravascular coagulation

Seminars in Perinatology

Volumn 37, Issue 4, 2013, Pages 257-266

  Hossain, Nazli ^a   Paidas, Michael J ^b  

^a DOW UNIVERSITY OF HEALTH SCIENCES   (Pakistan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation; Disseminated intravascular coagulation; Obstetrics; Pregnancy

Indexed keywords

ACTIVATED PROTEIN C; AMINOCAPROIC ACID; ANTITHROMBIN; ANTITHROMBIN III; D DIMER; FIBRIN; FIBRIN MONOMER; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HEPARIN; PLASMIN; PROCOAGULANT; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN ANTITHROMBIN COMPLEX; TRANEXAMIC ACID;

AMNION FLUID EMBOLISM; BLOOD CLOTTING; CRYOPRECIPITATION; DISSEMINATED INTRAVASCULAR CLOTTING; ECLAMPSIA; FETUS DEATH; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; HELLP SYNDROME; HUMAN; HYPOFIBRINOGENEMIA; HYPOVOLEMIA; INTRAUTERINE INFECTION; INTRAVENOUS ADMINISTRATION; LABORATORY DIAGNOSIS; LIVER FATTY DEGENERATION; METABOLIC ACIDOSIS; PARTIAL THROMBOPLASTIN TIME; PERINATAL INFECTION; PERINATAL MORBIDITY; PERINATAL MORTALITY; PLASMA TRANSFUSION; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; SCORING SYSTEM; SEPSIS; SOLUTIO PLACENTAE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; VAGINA BLEEDING;

EID: 84881091291     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2013.04.008     Document Type: Review

References (43)

1. Khan K.S., Wojdyla D., Say L., Gulmezoglu A.M., Van Look P.F. WHO analysis of causes of maternal death: a systematic review. Lancet 2006, 367(9516):1066-1074.
2. Berg C.J., Callaghan W.M., Syverson C., Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010, 116(6):1302-1309.
3. Dalaker K. Clotting factor VII during pregnancy, delivery and puerperium. Br J Obstet Gynaecol 1986, 93(1):17-21.
4. Cerneca F., Ricci G., Simeone R., Malisano M., Alberico S., Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997, 73(1):31-36.
5. Hansen AT, Andreasen BH, Salvig JD, Hvas AM. Changes in fibrin D-dimer, fibrinogen, and protein S during pregnancy. Scand J Clin Lab Invest. 71(2):173-176.
6. Krikun G., Huang S.T., Schatz F., Salafia C., Stocco C., Lockwood C.J. Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thromb Haemost 2007, 97(2):245-253.
7. Isler C.M., Rinehart B.K., Terrone D.A., Martin R.W., Magann E.F., Martin J.N. Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1999, 181(4):924-928.
8. Shamshirsaz A.A., Paidas M., Krikun G. Preeclampsia, hypoxia, thrombosis, and inflammation. J Pregnancy 2012, 374047.
9. Krikun G., Lockwood C.J., Paidas M.J. Tissue factor and the endometrium: from physiology to pathology. Thromb Res 2009, 124(4):393-396.
10. Rousseau A., Favier R., Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia?. Eur J Obstet Gynecol Reprod Biol 2009, 146(1):46-49.
11. Erez O., Gotsch F., Mazaki-Tovi S., Vaisbuch E., Kusanovic J.P., Kim C.J., et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death. J Matern Fetal Neonatal Med 2009, 22(8):672-687.
12. Shah N., Hossain N., Noonari M., Khan NH. Maternal mortality and morbidity of unsafe abortion in a university teaching hospital of Karachi, Pakistan. J Pak Med Assoc 2011, 61(6):582-586.
13. Harnett M.J., Hepner D.L., Datta S., Kodali B.S. Effect of amniotic fluid on coagulation and platelet function in pregnancy: an evaluation using thromboelastography. Anaesthesia 2005, 60(11):1068-1072.
14. Suzuki S., Watanabe S., Araki T. Acute fatty liver of pregnancy at 23 weeks of gestation. BJOG 2001, 108(2):223-224.
15. Castro M.A., Goodwin T.M., Shaw K.J., Ouzounian J.G., McGehee W.G. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy. Am J Obstet Gynecol 1996, 174(1 Pt 1):211-216.
16. Mousa H.A., Walkinshaw S. Major postpartum haemorrhage. Curr Opin Obstet Gynecol 2001, 13(6):595-603.
17. James A.H., McLintock C., Lockhart E. Postpartum hemorrhage: when uterotonics and sutures fail. Am J Hematol 2012, 87(Suppl 1):S16-S22.
18. Ledgerwood A.M., Blaisdell W. Coagulation challenges after severe injury with hemorrhagic shock. J Trauma Acute Care Surg 2012, 72(6):1714-1718.
19. Toh C.H., Samis J., Downey C., Walker J., Becker L., Brufatto N., et al. Biphasic transmittance waveform in the APTT coagulation assay is due to the formation of a Ca(++)-dependent complex of C-reactive protein with very-low-density lipoprotein and is a novel marker of impending disseminated intravascular coagulation. Blood 2002, 100(7):2522-2529.
20. Wada H., Mori Y., Okabayashi K., Gabazza E.C., Kushiya F., Watanabe M., et al. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Am J Hematol 2003, 72(1):1-7.
21. Takahashi H., Wada K., Niwano H., Shibata A. Comparison of prothrombin fragment 1 + 2 with thrombin-antithrombin III complex in plasma of patients with disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1992, 3(6):813-818.
22. de Lange N.M., Lance M.D., de Groot R., Beckers E.A., Henskens Y.M., Scheepers HC. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstet Gynecol Surv 2012, 67(7):426-435.
23. Sharma S.K., Philip J., Whitten C.W., Padakandla U.B., Landers D.F. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology 1999, 90(2):385-390.
24. Bakhtiari K., Meijers J.C., de Jonge E., Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med 2004, 32(12):2416-2421.
25. Onwuemene O., Green D., Keith L. Postpartum hemorrhage management in 2012: predicting the future. Int J Gynaecol Obstet 2012, 119(1):3-5.
26. Levi M., Toh C.H., Thachil J., Watson H.G. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009, 145(1):24-33.
27. Wikkelsoe A.J., Afshari A., Stensballe J., Langhoff-Roos J., Albrechtsen C., Ekelund K, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 2012, 13:110.
28. Thachil J., Toh C.H., Levi M., Watson HG. The withdrawal of activated protein C from the use in patients with severe sepsis and DIC [Amendment to the BCSH guideline on disseminated intravascular coagulation]. Br J Haematol 2012, 157(4):493-494.
29. Lockwood C.J., Bach R., Guha A., Zhou X.D., Miller W.A., Nemerson Y. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 1991, 165(5 Pt 1):1335-1341.
30. Levi M., van der Poll T., ten Cate H. Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006, 32(1):33-39.
31. Rey E., Garneau P., David M., Gauthier R., Leduc L., Michon N., et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial. J Thromb Haemost 2009, 7(1):58-64.
32. Urban G., Vergani P., Tironi R., Ceruti P., Vertemati E., Sala F., et al. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. Int J Fertil Womens Med 2007, 52(2-3):59-67.
33. Iba T., Saito D., Wada H., Asakura H. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a prospective multicenter survey. Thromb Res 2012, 130(3):e129-e133.
34. Kobayashi A., Matsuda Y., Mitani M., Makino Y., Ohta H. Assessment of the usefulness of antithrombin-III in the management of disseminated intravascular coagulation in obstetrically Ill patients. Clin Appl Thromb Hemost 2010, 16(6):688-693.
35. Kobayashi T., Tokunaga N., Sugimura M., Suzuki K., Kanayama N., Nishiguchi T., et al. Coagulation/fibrinolysis disorder in patients with severe preeclampsia. Semin Thromb Hemost 1999, 25(5):451-454.
36. Hossain N.S.T., Haider S., Soomro N., Khan N., Memon G., Ansari S., et al. Use of recombinant activated factor VII for massive postpartum hemorrhage. Acta Obstet Gynecol Scand 2007.
37. Welsh A., McLintock C., Gatt S., Somerset D., Popham P., Ogle R. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol 2008, 48(1):12-16.
38. Franchini M., Manzato F., Salvagno G.L., Lippi G. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review. Blood Coagul Fibrinolysis 2007, 18(7):589-593.
39. Levi M., Levy J.H., Andersen H.F., Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med 2010, 363(19):1791-1800.
40. McLintock C., James AH. Obstetric hemorrhage. J Thromb Haemost 2011, 9(8):1441-1451.
41. Franchini M., Franchi M., Bergamini V., Salvagno G.L., Montagnana M., Lippi G. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage. Semin Thromb Hemost 2008, 34(1):104-112.
42. Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int J Obstet Anesth. 19(2):218-223.
43. Rattray D.D., O'Connell C.M., Baskett T.F. Acute disseminated intravascular coagulation in obstetrics: a tertiary centre population review (1980 to 2009). J Obstet Gynaecol Can 2012, 34(4):341-347.